FDAnews Device Daily Bulletin

Protagen AG Debuts NavigAID Assay

Dec. 15, 2016

Germany-based Protagen AG launched NavigAID SSc, a stratification assay designed to assist in developing drugs for systemic sclerosis.

This assay enables segregation of patient subgroups by serum amount biomarkers.

NavigAID SSc is the most recent addition to the Protagen NavigAID portfolio. — Cynthia Jessup

View today's stories